Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma

NCT03974243 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-hodgkin's Lymphoma

Interventions

DRUG: Chiauranib
DRUG: Chidamide

Sponsor

Chipscreen Biosciences, Ltd.